Skip to main content
Premium Trial:

Request an Annual Quote

Biotech Incubator s War Chest Gets $2M Infusion

NEW YORK, Feb. 5 - Bioscience incubator LaunchCyte has secured $2 million in new funding, bringing its total capitalization to $4.6 million, the company said on Tuesday.


More than $1 million of that cash came from current investors, the company said. Investors include former Monsanto CEO Robert Shapiro and the Commonwealth of Pennsylvania.


LaunchCyte was founded in 2000 with the goal of propelling what it considers promising biotech companies to market. Its strategy is to identify biotech-based ideas, with a particular focus on bioinformatics technologies, and to supply seed money and help investigators begin and cultivate startups.


To date, the firm, based in Pittsburgh, has helped launch three companies: Morewood Molecular Sciences, focused on high-throughput screening and cancer diagnostics; genotyping firm Biodot; and sepsis therapeutic-research company Immunetrics.


LaunchCyte has said it hopes to create 25 companies within the next few years. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.